|
Clinical Trial Heberbiovac HB vaccine Material Reference Batch |
2011-05-16 |
CIGB |
|
NASVAC therapeutic vaccine study |
2011-05-16 |
CIGB |
|
Heberprovac Study |
2011-05-16 |
CIGB |
|
CERVISEG-300-I Study |
2011-05-17 |
CIGB |
|
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. |
2011-04-28 |
CIGB |
|
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. |
2011-04-29 |
CIGB |
|
NEUVITAL V Study |
2011-04-30 |
CIGB |
|
Change in Manufacture Process of Heberbiovac HB vaccine. |
2011-04-30 |
CIGB |
|
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
2011-04-27 |
CIGB |
|
CIGB500 in healthy volunteers |
2010-12-20 |
CIGB |
|
THERESA-2 Study |
2010-12-20 |
CIGB |
|
THERESA |
2008-10-07 |
CIGB |
|
Safety and immunogenicity of commercial Hepatitis B vaccines. |
2009-02-27 |
CIGB |
|
Dynamic-I |
2010-12-20 |
CIGB |
|
FarmaPEG-I |
2008-10-07 |
CIGB |
|
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
2010-06-11 |
CIGB |
|
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
2010-12-24 |
CIGB |
|
InCroMiel I |
2009-12-24 |
CIGB |
|
InCCNM -I |
2010-12-24 |
CIGB |
|
CITOPROT-III |
2009-02-26 |
CIGB |
